PubRank

H Corrodi

Author PubWeight™ 49.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J Pharm Pharmacol 1973 3.54
2 Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur J Pharmacol 1970 3.54
3 Effect of antidepressant drugs on the depletion of intraneuronal brain 5-hydroxytryptamine stores caused by 4-methyl-alpha-ethyl-meta-tyramine. Eur J Pharmacol 1969 2.61
4 Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,alpha-dimethyl-meta-tyramine. Eur J Pharmacol 1969 2.26
5 Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia 1966 1.71
6 Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 1970 1.33
7 ET495 and brain catecholamine mechanisms: evidence for stimulation of dopamine receptors. Eur J Pharmacol 1972 1.31
8 Evidence for a new type of dopamine receptor stimulating agent. J Pharm Pharmacol 1971 1.27
9 The effect of some psychoactive drugs on central monoamine neurons. Eur J Pharmacol 1967 1.23
10 The effect of immobilization stress on the activity of central monoamine neurons. Life Sci 1968 1.22
11 Ergocornine and 2-Br-alpha-ergocryptine. Evidence for prolonged dopamine receptor stimulation. Med Biol 1974 1.20
12 A possible role played by central monoamine neurones in thermo-regulation. Acta Physiol Scand 1968 1.17
13 Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br J Pharmacol 1968 1.15
14 Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine- -hydroxylase inhibitors. J Pharm Pharmacol 1972 1.13
15 Synthesis of some beta-adrenergic blocking agents. Acta Pharm Suec 1966 1.04
16 Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Eur J Pharmacol 1971 0.98
17 Minor tranquillizers, stress and central catecholamine neurons. Brain Res 1971 0.94
18 Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons. J Pharmacol Exp Ther 1971 0.94
19 Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation. Eur J Pharmacol 1975 0.94
20 Possible involvement of central adrenaline neurons in vasomotor and respiratory control. Studies with clonidine and its interactions with piperoxane and yohimbine. Eur J Pharmacol 1974 0.94
21 The effect of ethanol on the activity of central catecholamine neurones in rat brain. J Pharm Pharmacol 1966 0.89
22 Cardiac stimulant 1-(hydroxyphenoxy)-3-isopropylamino-2-propanols. Acta Pharm Suec 1970 0.88
23 Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor. Eur J Pharmacol 1970 0.87
24 [Fluorescence methods on histochemical visualization of monoamines. 5. Identification of fluorescent product from model experiments with 5-methoxytryptamine and formaldehyde]. Acta Histochem 1965 0.87
25 Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylase. Life Sci 1966 0.85
26 Oxotremorine and central monoamine neurons. Life Sci 1967 0.85
27 Effects of caffeine on central monoamine neurons. J Pharm Pharmacol 1972 0.83
28 The effects of barbiturates on the activity of the catecholamine neurones in the rat brain. J Pharm Pharmacol 1966 0.83
29 Dopamine beta-hydroxylase inhibitors. The preparation and the dopamine beta-hydroxylase inhibitory activity of some compounds related to dithiocarbamic acid and thiuramdisulfide. Acta Pharm Suec 1970 0.83
30 The effect of nerve activity on the depletion of the adrenergic transmitter by inhibitors of noradrenaline synthesis. Acta Physiol Scand 1967 0.82
31 Barbiturates and meprobamate: decreases in cathecholamine turnover of central dopamine and noradrenaline neuronal systems and the influence of immobilization stress. Brain Res 1972 0.81
32 Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase. Brain Res 1970 0.80
33 Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors. Brain Res 1978 0.79
34 The effect of neuroleptics on the activity of central catecholamine neurones. Life Sci 1967 0.79
35 Decreased turnover in central 5-HT nerve terminals induced by antidepressant drugs of the imipramine type. Eur J Pharmacol 1969 0.78
36 Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Eur J Pharmacol 1967 0.78
37 Fluorescence methods for the histochemical demonstration of monoamines. 4. Histochemical differentiation between dopamine and noradrenaline in models. J Histochem Cytochem 1966 0.78
38 Central monoamine neurons and pituitary-adrenal activity. Prog Brain Res 1970 0.78
39 Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors. Eur J Pharmacol 1974 0.78
40 Benzodiazepines and barbiturates: turnover changes in central 5-hydroxytryptamine pathways. Eur J Pharmacol 1974 0.77
41 Central serotonin neurons and thermoregulation. Adv Pharmacol 1968 0.77
42 Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reserpine or by an inhibitor of monoamine synthesis. J Pharm Pharmacol 1967 0.77
43 Blockade of the psychotic syndrome caused by nialamide in mice. J Pharm Pharmacol 1966 0.77
44 The effect of imipramine on central monoamine neurons. J Pharm Pharmacol 1968 0.77
45 Steric correlation between (--)-3-hydroxy-N-methylmorphinan and (--)-morphine and related compounds. J Pharm Pharmacol 1967 0.75
46 Effect of 6-hydroxydopamine on rat heart noradrenaline. Eur J Pharmacol 1971 0.75
47 The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition. Life Sci 1967 0.75
48 Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover. Adv Neurol 1975 0.75
49 Effect of isopropylnormetadrenaline and a catechol-O-methyltransferase inhibitor on adipose tissue metabolism in vitro. Acta Pharmacol Toxicol (Copenh) 1966 0.75
50 Renal lesions induced by alpha-methyltyrosine methylester and alpha-methyltyrosine. Acta Pharmacol Toxicol (Copenh) 1970 0.75
51 Histological and molecular biochemistry. Mod Probl Pharmacopsychiatry 1970 0.75
52 The effect of lithium on cerebral monoamine neurons. Psychopharmacologia 1967 0.75
53 The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover. Eur J Pharmacol 1971 0.75
54 Substituted metatyramines as brain monoamine depletors. Acta Pharm Suec 1970 0.75
55 Factors affecting the quality and intensity of the fluorescence in the histochemical method of demonstration of catecholamines. Acta Histochem 1966 0.75
56 Differences in the uptake of secondary catecholamines by the adrenergic nerves. Acta Physiol Scand 1967 0.75
57 The effect of psychotomimetic glycolate esters on central monoamine neurons. Eur J Pharmacol 1972 0.75
58 Interaction between cholinergic and catecholaminergic neurones in rat brain. Brain Res 1972 0.75
59 The effect of prolonged lithium administration on cerebral monoamine neurons in the rat. Life Sci 1969 0.75